The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
414
Unnamed facility
Tallinn, Estonia
Unnamed facility
Bordeaux, France
Unnamed facility
Brest, France
Occurrence of an alveolar osteitis
The primary Outcome measure will be evaluated based on the absence/presence of an alveolar osteitis within 7 days after the extraction of the third molar.
Time frame: Within 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Dijon, France
Unnamed facility
Le Petit-Quevilly, France
Unnamed facility
Lyon, France
Unnamed facility
Metz, France
Unnamed facility
Pierre-Bénite, France
Unnamed facility
Saint-Maixent-l'École, France
Unnamed facility
Strasbourg, France
...and 8 more locations